Drugs / WSE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03437668 | Dec 2018 → Jun 2023 | schizophrenia | Chengappa, K.N. Roy, MD | Terminated | Missed primary Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WSE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03437668 ↗ |